INFUSE BONE GRAFT UNK

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a consumer,health professional report with the FDA on 2019-03-06 for INFUSE BONE GRAFT UNK manufactured by Medtronic Sofamor Danek Usa, Inc.

Event Text Entries

[137935561] Product was not returned to the manufacturer for evaluation. Therefore, we are unable to determine the definitive cause of the reported event. X-ray review results: post-op x-rays for thoraco lumbar sacral stabilization shows a unilateral rod fracture at the lumbo sacral transition. By report occurred, 24 months post-op fusion status is unknown, degree of deformity correction is unknown, but there appears to be partial collapse of the vertebra at this level. An interbody graft is also present here. Although it is unknown whether the product caused or contributed to the reported event, we are filling this mdr for notification purpose. If information is provided in the future, a supplemental report will be issued.
Patient Sequence No: 1, Text Type: N, H10


[137935562] It was reported that on: (b)(6) 2017: the patient was presented with the following pre-op diagnosis: l4 hemivertebrae with spine deformity associated with low back pain and radiculopathy. He underwent the following procedures: t10 to ileum arthrodesis using bmp allograft and autograft. L4 pedicle resection. L3/5 cage replacement. Kyphotix correction and derotation. Continuous intraoperative neuromonitoring with sseps, meps and emg. Operative findings: resection of the right l4 pedicle and placement of interbody cage. Good sagittal and coronal correction based on intraoperative fluoro at the end of the procedure. As per operative notes,? We tried several temporary spacers and decided to place a 14 mm x 26 mm cage, which provided the best fit based on lateral x-ray. The peek cage was then opened and packed with autograft bone. The cage was then placed under intermittent fluoro to confirm good orientation and proper position. A similar 5. 5 mm cobalt chrome rod was then placed on the left an set screw were placed. Final lateral and ap x-rays show good cage placement as well as good correction of the kyphotic and scoliotic deformity. Once we were satisfied with the cage placement and deformity correction, final tightening was performed. The incision was copiously irrigated before the arthrodesis was performed. Using the high-speed drill, we decorticated from t10 to the ileum and packed the posterolateral margins with bmp and mixture of allograft and autograft. A medium-medium drain was placed and secured to the skin". On (b)(6) 2017: patient presented for 6-week post-operative appointment after staged procedure for thoracolumbar scoliosis correction with l4 vertebrectomy. He had history of imperforate anus, colostomy with chronic back pain and leg pain and scoliosis. His rle radicular pain that he had immediately after surgery has dissipated. His primary area of pain is in his low back and buttock on the left side. On (b)(6) 2017: patient presented for 3 months post-operative appointment. He has noticed an increase in his lower back pain and some left leg symptoms since that decreased. On (b)(6) 2017: the patient was presented with the following pre-op diagnosis: lumbar scoliotic deformity s/p t10-ilium fusion, with hardware failure. He underwent the following procedures: exploration of prior thoracolumbar instrumented fusion on the right side. With removal and replacement of right sided fractured rod. Placement of new right sided satellite rod. Placement of second right iliac screw. Operative findings: right sided fractured rod removed and replaced with two new cobalt chromium rods. Second right sided iliac screw placed to reinforce construct. On (b)(6) 2017: patient presented for 6 weeks post-operative appointment after revision t10 to ilium fusion after fracture of right rod. He denies any significant lower extremity pain. In general, he feels as through he is making significant progress. On (b)(6) 2017: the patient underwent x-ray thoracolumbar spine ap lateral examination. Impression: no displacement of fixation hardware following instrumentation from t10 to posterior iliac. On (b)(6) 2018: the patient presented for a follow-up visit. Assessment: status post right fusion. Osteoarthritis of first metatarsophalangeal joint. On (b)(6) 2018: patient presented for 6 months post-operative appointment after revision t10 to ilium fusion after fracture of right rod. He feels as though he is somewhat improved compared to pre-op but is frustrated that the left buttock and thigh symptoms persist.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1030489-2019-00225
MDR Report Key8393522
Report SourceCONSUMER,HEALTH PROFESSIONAL
Date Received2019-03-06
Date of Report2019-08-22
Date Mfgr Received2019-04-09
Date Added to Maude2019-03-06
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactSTACIE ZIEMBA
Manufacturer Street1800 PYRAMID PLACE
Manufacturer CityMEMPHIS TN 38132
Manufacturer CountryUS
Manufacturer Postal38132
Manufacturer Phone9013963133
Manufacturer G1MEDTRONIC SOFAMOR DANEK USA, INC
Manufacturer Street4340 SWINEA RD
Manufacturer CityMEMPHIS TN 38118
Manufacturer CountryUS
Manufacturer Postal Code38118
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameINFUSE BONE GRAFT
Generic NameFILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET
Product CodeNEK
Date Received2019-03-06
Model NumberNA
Catalog NumberUNK
Lot NumberUNK
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device AgeDA
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerMEDTRONIC SOFAMOR DANEK USA, INC
Manufacturer Address4340 SWINEA RD MEMPHIS TN 38118 US 38118


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2019-03-06

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.